102 related articles for article (PubMed ID: 20943461)
1. Increased susceptibility to experimental steatohepatitis induced by methionine-choline deficiency in HBs-Tg mice.
Fu MM; Sun R; Tian ZG; Wei HM
Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):513-9. PubMed ID: 20943461
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
3. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
[TBL] [Abstract][Full Text] [Related]
4. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
Yamazaki Y; Kakizaki S; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
[TBL] [Abstract][Full Text] [Related]
5. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
Rangnekar AS; Lammert F; Igolnikov A; Green RM
Liver Int; 2006 Oct; 26(8):1000-5. PubMed ID: 16953841
[TBL] [Abstract][Full Text] [Related]
6. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
8. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
9. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
12. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
Itagaki H; Shimizu K; Morikawa S; Ogawa K; Ezaki T
Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355
[TBL] [Abstract][Full Text] [Related]
13. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
[TBL] [Abstract][Full Text] [Related]
14. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
Yamazaki Y; Kakizaki S; Horiguchi N; Sohara N; Sato K; Takagi H; Mori M; Negishi M
Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
[TBL] [Abstract][Full Text] [Related]
15. Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.
Salamone F; Galvano F; Marino Gammazza A; Paternostro C; Tibullo D; Bucchieri F; Mangiameli A; Parola M; Bugianesi E; Li Volti G
Dig Liver Dis; 2012 Apr; 44(4):334-42. PubMed ID: 22197629
[TBL] [Abstract][Full Text] [Related]
16. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
[TBL] [Abstract][Full Text] [Related]
17. Teucrium polium in prevention of steatohepatitis in rats.
Amini R; Nosrati N; Yazdanparast R; Molaei M
Liver Int; 2009 Sep; 29(8):1216-21. PubMed ID: 19602140
[TBL] [Abstract][Full Text] [Related]
18. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis.
Marcolin E; Forgiarini LF; Tieppo J; Dias AS; Freitas LA; Marroni NP
Arq Gastroenterol; 2011; 48(1):72-9. PubMed ID: 21537547
[TBL] [Abstract][Full Text] [Related]
19. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
dela Peña A; Leclercq IA; Williams J; Farrell GC
J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
[TBL] [Abstract][Full Text] [Related]
20. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium.
Sahai A; Pan X; Paul R; Malladi P; Kohli R; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G55-62. PubMed ID: 16439472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]